UK markets open in 5 hours

Hyloris Pharmaceuticals SA (HYL.BR)

Brussels - Brussels Delayed price. Currency in EUR
Add to watchlist
11.700.00 (0.00%)
At close: 05:37PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 327.60M
Enterprise value 298.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)116.42
Price/book (mrq)8.44
Enterprise value/revenue 106.13
Enterprise value/EBITDA -19.88

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-7.87%
S&P500 52-week change 323.57%
52-week high 314.10
52-week low 310.60
50-day moving average 311.97
200-day moving average 312.15

Share statistics

Avg vol (3-month) 310.67k
Avg vol (10-day) 35.72k
Shares outstanding 528M
Implied shares outstanding 628M
Float 8N/A
% held by insiders 156.62%
% held by institutions 10.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-548.55%

Management effectiveness

Return on assets (ttm)-18.54%
Return on equity (ttm)-33.95%

Income statement

Revenue (ttm)2.81M
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)80.20%
Gross profit (ttm)N/A
EBITDA -15.74M
Net income avi to common (ttm)-15.76M
Diluted EPS (ttm)-0.56
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.7M
Total cash per share (mrq)N/A
Total debt (mrq)1.75M
Total debt/equity (mrq)4.51%
Current ratio (mrq)5.09
Book value per share (mrq)1.97

Cash flow statement

Operating cash flow (ttm)-12.73M
Levered free cash flow (ttm)-7.78M